Tolemy Bio
PrivateLast Round
Pre Seed
May 12, 2026
Total Funding Raised
$1.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tolemy Bio operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Pre Seed round in May 2026.
Tolemy Bio is a biotechnology company that develops an AI-native platform, Orbit, to help biopharma teams interpret, optimize, and control cell-based therapeutic processes for drug development and manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Healthcare Analytics, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tolemy Bio Comparables
Compare Tolemy Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeepLife | 79% | |
| BioReact | 76% | |
| Somite AI | 76% |
For institutional investors. Book with your work email.
Tolemy Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Tolemy Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redbus Group | Pre Seed |
| JME Venture Capital | Pre Seed |
| Norrsken Foundation | Pre Seed |
| Masia | Pre Seed |
| Big Sur Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
$2M round led by Norrsken Evolve.
- Apr 16, 2026
Monthly visitors grew 98% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Tolemy Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tolemy Bio's valuation, stock price, and market status.
Is Tolemy Bio a public or private company?
Tolemy Bio is a private company.
What is the current stock price of Tolemy Bio?
Tolemy Bio is a private company, so its shares have no public market price. Caplight tracks Tolemy Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tolemy Bio worth (valuation)?
Valuation information for Tolemy Bio is not publicly available.
Can I buy Tolemy Bio stock?
Tolemy Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tolemy Bio's last funding round?
Tolemy Bio's most recent funding round was Pre Seed on May 12, 2026.
Who are the main investors in Tolemy Bio?
Key investors in Tolemy Bio include Norrsken Foundation.
Will Tolemy Bio IPO soon?
No public IPO plans have been announced for Tolemy Bio.
How can I track Tolemy Bio secondary market activity?
Caplight tracks bids, offers, and trades in Tolemy Bio's shares on secondary markets.